RDX5791, a First-in-Class Minimally Systemic NHE3 Inhibitor in Clinical Development for CIC and IBS-C, Increases Intestinal Sodium Leading to Enhanced Intestinal Fluid Volume and Transit

✍ Scribed by Andrew G. Spencer; Jeffrey W. Jacobs; Michael R. Leadbetter; Christopher W. Carreras; Xunxiang Du; Noah Bell; Samantha Koo-McCoy; Jill N. Kohler; Eric Labonté; David P. Rosenbaum; Marc Navre; Dominique Charmot

• Book ID: 119432252
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 90 KB
• Volume: 140
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/s0016-5085(11)60405-8